ReviewFrontiers in pharmacology2026

Emerging targeted therapies for primary immune thrombocytopenia: novel agents, combination strategies, and future directions.

Zhen Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.